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Abstract
Background: There is growing evidence that environmental peanut exposure through 
non‐oral routes, including the skin and respiratory tract, can result in peanut sensiti-
zation. Environmental adjuvants in indoor dust can promote sensitization to inhaled 
antigens, but whether they contribute to peanut allergy development is unclear.
Objective: We investigated whether indoor dust promotes airway sensitization to 
peanut and peanut allergy development in mice.
Methods: Female and male C57BL/6J mice were exposed via the airways to peanut, 
indoor dust extract, or both for 2 weeks. Mice were then challenged with peanut and 
assessed for anaphylaxis. Peanut‐specific immunoglobulins, peanut uptake by lung 
conventional dendritic cells (cDCs), lung innate cytokines, and T cell differentiation in 
lung‐draining lymph nodes were quantified. Innate cytokine production by primary 
human bronchial epithelial cells exposed to indoor dust was also determined.
Results: Inhalational exposure to low levels of peanut in combination with indoor dust, 
but neither alone, resulted in production of peanut‐specific IgE and development of 
anaphylaxis upon peanut challenge. Indoor dust triggered production of innate cy-
tokines in murine lungs and in primary human bronchial epithelial cells. Additionally, 
inhaled indoor dust stimulated maturation and migration of peanut‐laden lung type 
1 cDCs to draining lymph nodes. Inhalational exposure to peanut and indoor dust 
induced peanut‐specific T helper 2 cell differentiation and accumulation of T follicu-
lar helper cells in draining lymph nodes, which were associated with increased B cell 
numbers and peanut‐specific immunoglobulin production.
Conclusions & clinical relevance: Indoor dust promotes airway sensitization to pea-
nut and development of peanut allergy in mice. Our findings suggest that environ-
mental adjuvants in indoor dust may be determinants of peanut allergy development 
in children.
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1  | INTRODUC TION
Peanut allergy (PA) is a growing public health concern, affecting 
roughly 2% of the population in industrialized countries.1,2 PA is usu-
ally lifelong3 and is responsible for the majority of deaths related to 
food allergy.4 While early‐life peanut consumption has shown prom-
ise in reducing PA development,5 a significant number of infants are 
already sensitized to peanut prior to introduction.5,6 How peanut 
sensitization develops during early infancy is unclear, but there is 
growing evidence that environmental peanut exposure plays an im-
portant role.7‐10 Biologically active peanut is detectable in dust col-
lected from homes,9,11,12 and the levels of peanut allergen in indoor 
dust directly correlate with rates of peanut sensitization and prob-
able PA in children at high risk for PA.8,9,13 However, environmental 
peanut exposure was not associated with peanut sensitization in 
children without atopic risk factors,13 suggesting that other indoor 
environmental factors may influence the risk of peanut sensitization. 
Understanding the environmental determinants of peanut sensiti-
zation will be essential for creating effective interventions aimed at 
preventing PA development.
The vast majority of PA subjects react upon their first known 
ingestion of peanut,14 suggesting sensitization occurs through non‐
oral routes of exposure. While there is evidence that cutaneous 
exposure to peanut through an impaired skin barrier can result in 
sensitization,8-10 recent studies in rodents have shown that inhala-
tional exposure to peanut can also lead to sensitization and anaphy-
laxis to peanut allergen.15‐17 In addition, peanut‐specific CD4+ T cells 
from PA subjects express both airway‐ and skin‐homing chemokine 
receptors, suggesting that peanut sensitization may occur through 
the skin and respiratory tract.18 While peanut allergen is not thought 
to be airborne in homes,11 the physical proximity of infants to floors, 
as well as their rapid respiratory rates, likely increases their risk for 
inhalational exposure to peanut in indoor dust.19 Thus, inhalational 
exposure to environmental peanut is a plausible route for peanut 
sensitization during infancy.
Sensitization to inhaled allergens involves both innate and adap-
tive immune responses in the lungs.20 Inhaled allergens are taken 
up by lung conventional dendritic cells (cDCs), which then migrate 
to draining lymph nodes and present antigen to CD4+ T helper 
cells.21 Allergens also trigger airway epithelial cells to release in-
nate cytokines, including interleukin (IL)‐1, IL‐33, and thymic stro-
mal lymphopoietin (TSLP), which in turn programme lung cDCs to 
induce differentiation of allergen‐specific T helper 2 (Th2) cells.22-24 
Through the secretion of IL‐4 and IL‐13, Th2 cells promote allergen‐
specific IgE production by B cells.25 Although Th2 cells have histori-
cally been considered the primary mediators of allergic sensitization, 
there is growing evidence that T follicular helper (Tfh) cells also play 
a critical role in promoting IgE production.15,26‐28 Through their abil-
ity to provide help to germinal centre B cells, Tfh cells promote an-
tibody isotype class switching and B cell differentiation into plasma 
and memory cells.29 Accordingly, recent studies have shown that 
Tfh cells are essential for the development of IgE responses against 
inhaled antigens.15,27,28 Like other T helper cell subsets, cDCs are 
necessary for priming antigen‐specific Tfh cells.30-32 While several 
studies have investigated the role of lung cDCs in promoting Th2 
responses,33-35 the mechanisms by which lung cDCs prime allergen‐
specific Tfh cells remain poorly understood.
In addition to food allergens, indoor dust contains a mixture of 
environmental agents with immunostimulatory properties, includ-
ing endotoxin, fungal‐derived polysaccharides, and proteases.36‐39 
These environmental agents can act as adjuvants in the respira-
tory tract and promote allergic sensitization to normally innocuous 
antigens in animal models.40-44 It is likely that the composition of 
environmental adjuvants in indoor dust can significantly influence 
sensitization and allergy development. Indeed, the bioactivity of 
indoor dust has been associated with aeroallergen sensitization in 
children at risk for allergy.37 We have previously shown that indoor 
dust extracts can programme lung cDCs to induce Th2 responses 
to inhaled antigens, resulting in the development of allergic airway 
inflammation upon subsequent inhalational allergen challenge.42,45 
Whether adjuvants in indoor dust can also promote the development 
of allergy to environmental food allergens is unknown. To address 
this question, we developed an animal model that mimics inhala-
tional exposure to environmental peanut allergen. We found that in-
halational coexposure to peanut and indoor dust, but neither alone, 
induced peanut‐specific IgE and IgG1 production. Importantly, mice 
sensitized with peanut and indoor dust developed anaphylaxis upon 
peanut challenge. Inhalational exposure to indoor dust triggered the 
release of innate cytokines in both murine lungs and primary human 
bronchial epithelial cells. Furthermore, inhaled indoor dust stimu-
lated the maturation and migration of peanut‐laden cDCs to lung‐
draining lymph nodes (LNs), which was associated with induction of 
peanut‐specific Th2 and Tfh cell differentiation. Collectively, these 
findings suggest that environmental adjuvants in indoor dust are de-
terminants for PA development in children.
2  | METHODS
2.1 | Mice
C57BL/6J were obtained from the Jackson Laboratories (Bar Harbor, 
ME) and bred at the University of North Carolina at Chapel Hill. All 
mice were housed in specific pathogen‐free conditions, raised on 
standard mouse chow free of any peanut‐ingredients, and kept on 
a 12:12‐hour light/dark cycle. Female and male mice were used for 
experiments between 6 and 12 weeks of age. All animal experiments 
were approved by the Institutional Animal Care and Use Committee 
at the University of North Carolina at Chapel Hill.
2.2 | Reagents
Peanut allergen extract was prepared from roasted de‐fatted pea-
nut flour (Golden Peanut) in PBS with 1 M NaCl as described previ-
ously.46 Extracts of indoor dust (ID) were prepared as previously 
described.47 Briefly, vacuumed dust samples were collected from a 
single‐family residence over several months to minimize sampling 
variability. Pooled dust samples were passed through a coarse 
sieve, weighed, and then extracted at 100 mg/mL with PBS at 4°C 
with mild agitation for 16 hours. The samples were centrifuged to 
remove insoluble debris, and supernatants were sterilized by pas-
sage through a 0.22‐μm filter. Endotoxin levels in the experimental 
ID samples were 73 ng/mL (730 EU/mL) as determined by Limulus 
amebocyte lysate assay (Thermo Scientific). Total peanut protein 
in ID samples was determined to be 172 ng/mL (or 1.72 µg/g dust) 
as measured by the Veratox for Peanut Allergen Assay (Neogen, 
Lansing, MI). Ambient levels of the major peanut allergens Ara h 
2 and 3 in ID samples were 3.6 and 8.4 ng/mL, respectively, as 
measured by ELISA (Indoor Biotechnologies). Indoor dust extracts 
were aliquoted, stored at −80°C, and discarded after more than 
two freeze‐thaw cycles.
2.3 | Peanut airway sensitization and 
challenge model
Mice were lightly anaesthetized by isoflurane inhalation and given 
0.005-50 μg of peanut alone or with 10 μL of ID in a total volume 
of 50 μL by oropharyngeal (o.p.) aspiration twice weekly for two 
weeks as previously described.41,48 Serum was collected by sub-
mandibular bleed at the indicated time‐points for immunoglobulin 
quantification. Seven days after the last sensitization (day 17), mice 
were challenged to peanut (8 mg protein) by intraperitoneal (i.p.) in-
jection. Core body temperatures were monitored every 15 minutes 
with a rectal thermometer (Physitemp). Anaphylaxis was defined as 
a greater than 3°C decrease in body temperature.
2.4 | ELISA for peanut‐specific 
antibodies and cytokines
Peanut‐specific IgE, IgG1, and IgG2c were quantified via ELISA as 
described previously.49 Briefly, 96‐well plates were coated with 
20 µg/mL HSA‐DNP (for standard curves) or peanut extract (for 
samples), and blocked with 2% BSA in PBS‐0.5% Tween. Samples 
were diluted 1:20 for peanut‐specific IgE, 1:20 000 for peanut‐spe-
cific IgG1, and 1:10 000 for peanut‐specific IgG2c ELISAs. Standard 
curves ranging from 0.002 to 2 μg/mL of either mouse IgE anti‐DNP, 
IgG1 anti‐DNP, or IgG2c anti‐DNP (Accurate Chemicals) were gener-
ated via 1:2 serial dilutions. IgE plates were detected with the fol-
lowing antibodies in succession: sheep IgG anti‐mouse IgE (0.5 μg/
mL, The Binding Site), biotinylated donkey anti‐sheep IgG (0.5 µg/
mL, Accurate Chemicals), and NeutrAvidin‐HRP (0.5 µg/mL, Pierce 
Biotechnology). IgG1 and IgG2c plates were detected with HRP‐goat 
anti‐mouse IgG1 (1:40 000, Southern Biotech) or IgG2c (1:20 000, 
Southern Biotech), respectively. All plates were developed using TMB 
(SeraCare) and stopped using 1% HCl (SeraCare). Immunoglobulin 
ELISA plates were read at 450 nm using a microplate spectropho-
tometer (BioTek Instruments). Measurement of mouse cytokines 
was performed using the following commercial ELISA kits: IL‐1α, 
IL‐1β, and IL‐33 (R&D Systems); IL‐4, TSLP, and IFN‐γ (BioLegend); 
IL‐13 (eBioscience); and IL‐5 (BD Biosciences).
2.5 | Cytokine production by lung‐draining LNs
Mice were exposed to peanut, ID, or both via the airways twice 
weekly for 2 weeks as described above. On day 14, mediastinal 
LNs (mLNs) were harvested and passed through a 70‐μm strainer 
to obtain a single‐cell suspension. LN cells (200 000 cells/well) were 
cultured for 4 days in complete RPMI 10 medium (RPMI‐1640, 10% 
fetal bovine serum (Gemini), penicillin‐streptomycin, 50 μmol/L 2‐
mercaptoethanol, 10 mmol/L HEPES) and peanut (100 μg/mL) in a 
96‐well round‐bottom plate. Supernatants were collected 4 days 
later, and cytokines were measured by ELISA.
2.6 | Analysis of cytokines in whole lungs
Mice were exposed to peanut, ID, or both via the airways by o.p. 
administration. Six hours later, lungs were collected, weighed, and 
snap‐frozen in liquid nitrogen. Frozen lungs were suspended in 
PBS with protease inhibitors (Roche Diagnostics) at 1.5 volumes 
(g lung/mL PBS) and homogenized using a VWR‐200 homogenizer. 
Total protein content was determined with a BCA assay (Pierce 
Biotechnology). Cytokine levels were measured by ELISA and nor-
malized to total protein in the lung homogenates.
2.7 | Primary human bronchial epithelial cell (HBEC) 
culture and cytokine analysis
Human donor lungs unsuitable for transplantation were ob-
tained following informed consent for research use under proto-
col #03‐1396, approved by the University of North Carolina at 
Chapel Hill Biomedical Institutional Review Board. Primary human 
bronchial epithelial cells (HBECs) were obtained by enzymatic di-
gestion as described.50 Cells from three non‐smoker donors with 
no prior history of chronic lung disease were grown on plastic in 
bronchial epithelial growth media for two passages before cul-
ture under air‐liquid interface (ALI) conditions on culture inserts 
(6.5 mm diameter, polyester 0.4 μm pore size; Costar 3470, Fisher 
Scientific). Peanut (50 μg/mL), ID extract (10% v/v), or both were 
applied to the apical cell surface of fully differentiated HBEC cul-
tures. Four hours later, apical washes were collected for cytokine 
analysis. Measurement of human cytokines was performed using 
IL‐1α, IL‐1β, IL‐33, and TSLP ELISA kits (R&D Systems).
2.8 | Flow cytometric analysis of lung and LN cells
Murine lung and LN cells were isolated and analysed by flow cy-
tometry as previously described.51,52 Briefly, harvested lungs and 
mLNs were manually cut with scissors and digested with Liberase 
TM (100 μg/mL; Roche Diagnostics), collagenase XI (250 μg/mL), 
hyaluronidase 1a (1 mg/mL), and DNase I (200 μg/mL; Sigma, St. 
Louis, MO) for 1 hour (lungs) or 30 minutes (mLNs) at 37°C. The 
digested tissue was passed through a 70‐µm nylon strainer to 
obtain a single‐cell suspension. Red blood cells were lysed with 
0.15 M ammonium chloride and 1 mmol/L potassium bicarbonate 
(ACK lysis). Cells were incubated with anti‐mouse CD16/CD32 
(2.4G2) for 5 minutes to block Fc receptors, followed by incuba-
tion with fluorochrome‐ or biotin‐conjugated antibodies against 
murine CD3ε (145‐2C11), CD4 (GK1.5), CD11b (M1/70), CD11c 
(N418), CD19 (6D5), CD44 (IM7), CD45 (30‐F11), CD88 (20/70), 
CD103 (M290), Ly‐6C (AL‐21), Ly‐6G (1A8), I‐A/E (M5/114.15.2), 
CXCR5 (L138D7), PD‐1 (29F.1A12), and Siglec‐F (E50‐2440) for 
30 minutes on ice. Staining with biotinylated antibodies was fol-
lowed by incubation with fluorochrome‐conjugated streptavidin 
for 20 minutes on ice. Cells were also concurrently stained with 
Zombie Aqua (BioLegend) for live cell/dead cell discrimination. 
Flow cytometry data were acquired with a four‐laser LSRII (BD 
Biosciences) and analysed using FlowJo (Ashland, OR) software. 
Only single cells were analysed. All antibodies were purchased 
from BioLegend or BD Biosciences. In some experiments, pea-
nut uptake by lung cDCs was evaluated following instillation of 
peanut labelled with Alexa Fluor 647 (Invitrogen) as described 
previously.51,52
2.9 | Statistical analysis
GraphPad Prism version 8 was used to analyse all data. Paired t 
tests, and one‐ or two‐way ANOVA tests were performed, and a P-
value < .05 was considered significant.
3  | RESULTS
3.1 | Environmental adjuvants in indoor dust 
promote airway sensitization to peanut
Prior studies have shown that inhalational exposure to peanut 
and other food allergens can result in sensitization.15‐17 However, 
these studies involved airway delivery of either allergen alone 
or in combination with cholera toxin as an adjuvant. To more 
accurately replicate natural exposure to environmental peanut 
in within the home, we coadministered peanut (50 µg) with in-
door dust extract (ID) to the airways of mice twice weekly for 
two weeks (Figure 1A). Inhalational exposure to peanut and ID 
resulted in marked production of peanut‐specific IgE, IgG1, and 
IgG2c (Figure 1B). Peanut‐specific IgE and IgG1 were detectable 
as early as one week after the initial exposure, whereas IgG2c 
was not detectable until after two weeks of exposure (Figure 1B). 
In contrast, inhalational exposure to peanut alone induced only 
modest levels of peanut‐specific IgE and very low levels of IgG1. 
Consistent with the very low levels of peanut allergen measured 
in our ID preparation, inhalational exposure to ID alone did not 
induce peanut‐specific immunoglobulins. Thus, ID has potent 
adjuvant activity that promotes airway sensitization to inhaled 
peanut.
F I G U R E  1   Indoor dust promotes 
airway sensitization to peanut. A, 
Experimental schematic for peanut 
sensitization. B, Peanut‐specific IgE, 
IgG1, and IgG2c quantified on days 0, 7, 
and 14 of sensitization regimen. C, Core 
body temperatures recorded after i.p. 
challenge to peanut. Symbols represent 
means ± SEM (n = 6 mice per group). 
Data shown are from a single experiment, 
representative of three experiments. 
Statistical comparisons are between 
PN + ID and PN groups. *P < .05, **P < .01, 
***P < .001, two‐way ANOVA. ID, indoor 
dust; PN, peanut
To determine whether airway sensitization to peanut would re-
sult in clinical reactivity upon systemic challenge, sensitized mice 
were administered an i.p. injection of peanut allergen. Mice sen-
sitized with peanut and ID exhibited a dramatic decrease in body 
temperature after challenge, consistent with the development of 
anaphylaxis (Figure 1C). In contrast, mice sensitized with neither 
ID nor peanut alone exhibited a substantial decrease in body tem-
perature after challenge (Figure 1C). Taken together, these findings 
demonstrate that environmental adjuvants in ID promote sensitiza-
tion to inhaled peanut, resulting in the development of anaphylaxis 
after systemic challenge.
3.2 | Indoor dust induces sensitization to low 
levels of inhaled peanut
In the United States, environmental sampling studies have re-
ported the median peanut concentration in household dust to be 
roughly 25‐40 µg/g.9,53 It is estimated that infants are exposed 
to 50‐100 mg of indoor dust daily,54 indicating that average envi-
ronmental exposure to peanut allergen is likely low. We therefore 
investigated whether ID would promote sensitization to low levels 
of peanut allergen. When combined with ID, inhalational expo-
sure to as little as 500 ng of peanut resulted in sensitization, as 
evident by production of peanut‐specific IgE and IgG1 (Figure 2A). 
Importantly, mice exposed to 500 ng of peanut in combina-
tion with ID demonstrated anaphylaxis upon peanut challenge 
(Figure 2B). Exposure to 5 ng of peanut and ID did not result in 
sensitization or anaphylaxis upon peanut challenge (Figure 2A,B), 
indicating that the threshold for peanut sensitization in our model 
was in the range of 5‐500 ng of peanut allergen. Furthermore, ex-
posure to ID alone, which contained 1.72 ng peanut protein per 
o.p. administration, nor peanut alone, resulted in sensitization or
anaphylaxis upon peanut challenge (Figure 2A,B). Thus, adjuvants
in ID facilitate sensitization to low and likely environmentally rel-
evant levels of peanut allergen.
3.3 | Inhaled indoor dust induces innate cytokine 
production in murine lungs and primary HBECs
Stimulation of innate immune responses is a critical step for al-
lergic sensitization in the lungs.25,55 Inhaled allergens and other 
noxious agents can trigger release of innate cytokines (IL‐33, TSLP, 
IL‐1) by airway epithelial cells, which in turn act upon DCs and in-
nate lymphoid cells to promote Th2 responses.20 Furthermore, 
IL‐1 signalling has also been shown to promote allergen‐specific 
IgE production to inhaled allergens.15 We therefore investigated 
whether environmental adjuvants in ID stimulated innate cytokine 
production in the lungs. Inhalational exposure to ID resulted in a 
marked increase in IL‐1α, IL‐1β, and IL‐33 in the lungs at 6 hours 
post‐exposure (Figure 3A). Consistent with prior studies,15 inha-
lational exposure to peanut alone induced a modest increase in 
lung levels of IL‐1α and IL‐1β, but not IL‐33 (Figure 3A). Inhalational 
exposure to combined peanut and ID induced similar levels of IL‐1α 
and IL‐1β cytokines compared to ID alone, indicating that ID and 
peanut did not have synergistic effects on innate cytokine produc-
tion (Figure 3A). Interestingly, TSLP lung levels were increased in 
mice exposed to peanut but not ID, suggesting that peanut can 
directly stimulate TSLP production (Figure 3A).
We next investigated whether ID could induce innate cyto-
kine production by human airway epithelial cells. Treatment of 
primary HBECs with ID for four hours resulted in apical secretion 
of IL‐1α and IL‐1β (Figure 3B). Treatment of HBECs with peanut 
alone did not induce innate cytokine production (Figure 3B), sug-
gesting that the endogenous adjuvant activity of peanut is not 
due to direct stimulation of airway epithelial cells. We did not 
detect induction of IL‐33 or TSLP in peanut‐ or ID‐treated HBECs 
(data not shown), although we cannot exclude the possibility 
that these cytokines are produced at later time‐points. Taken 
together, these findings indicate that acute exposure to ID can 
induce innate cytokine production in murine lungs and in human 
airway epithelial cells.
F I G U R E  2   Indoor dust induces 
sensitization to low levels of inhaled 
peanut. A, Peanut‐specific IgE, IgG1, 
and IgG2c quantified on days 0, 7 and 
14 of sensitization regimen. Mice were 
sensitized with varying amounts of 
PN (50 µg, 0.5 µg, 5 ng) +ID. B, Core 
body temperatures recorded after i.p. 
challenge to peanut. Symbols represent 
means ± SEM of pooled data from 3 
experiments (n = 5‐12 mice per group). 
Statistical comparisons are between 
PN + ID and PN groups. *P < .05, **P < .01, 
***P < .001, two‐way ANOVA. ID, indoor 
dust; PN, peanut
3.4 | Indoor dust enhances activation and 
migration of peanut‐laden cDC1s to lung‐draining LNs
Through their ability to capture antigens and stimulate naïve T cells, 
cDCs play a critical role in initiating adaptive immune responses 
against inhaled allergens.21 Two major subsets of cDCs have been 
described in the lungs: CD103+XCR1+ cDC1s and CD11b+SIRPα+
cDC2s.56 Both cDC1s and cDC2s have been reported to capture and 
shuttle inhaled antigens to LNs.33,34 To determine whether ID affects 
antigen uptake by lung cDCs, we administered fluorescent‐labelled 
peanut allergen (PN‐AF647) to the airways of mice either alone or 
in combination with ID. After 24 hours, lungs were harvested and 
uptake of PN‐AF647 by lung cDC subsets was determined by flow 
cytometry (Figure S1A). Uptake of inhaled PN‐AF647 was similar 
between lung cDC1s and cDC2s and was not affected by coadmin-
istration of ID, indicating that ID did not enhance antigen capture by 
DCs (Figure 4A,B).
In addition to antigen capture, migration of lung cDCs to LNs is 
necessary for optimal induction of adaptive immune responses.57 To 
determine whether inhaled ID affected migration of DCs to lung‐
draining mLNs, we administered peanut with or without ID to the 
airways of mice. After 24 hours, lung‐draining mLNs were harvested 
and the frequencies of migratory and resident cDCs were determined 
by flow cytometry (Figure S1B). Compared to peanut alone, ID expo-
sure markedly increased the number of migratory lung cDCs in mLNs 
(Figure 4C). In addition, inhaled ID resulted in activation of migratory 
cDCs, as indicated by increased costimulatory molecule expression 
(Figure 4D) compared to peanut exposure alone. To measure mi-
gration of antigen‐laden DCs to mLNs, we administered PN‐AF647 
with or without ID to the airways. After 24 hours, the percentage of 
peanut‐laden (PN‐AF647+) cDCs in mLNs was determined by flow 
cytometry. Interestingly, nearly 30% of migratory cDC1s were PN‐
AF647+ compared to about 5% of cDC2s (Figure 4E). Coexposure 
to ID did not significantly increase the percentage of PN‐AF647+ 
cDC1s or cDC2s in mLNs (Figure 4E). However, the absolute num-
ber of peanut‐laden cDC1s was dramatically increased in mLNs from 
ID‐exposed mice (Figure 4F). In summary, inhaled ID induced the ac-
tivation and migration of peanut‐laden cDC1s to lung‐draining LNs.
3.5 | Inhaled ID induces peanut‐specific Th2 
cells and accumulation of Tfh cells in lung‐
draining LNs
The induction of IL‐4–secreting Th cells is necessary for the develop-
ment of peanut‐specific IgE production by B cells. Therefore, we in-
vestigated whether ID promoted IL‐4 production by peanut‐specific 
T cells in lung‐draining LNs. Mice were exposed to inhaled peanut, 
ID, or both twice weekly. After 2 weeks, mLN cells from exposed 
mice were collected and stimulated ex vivo with peanut allergen to 
assess Th cell cytokine production. Upon stimulation with peanut 
allergen, mLN cells from mice exposed to peanut and ID, but neither 
alone, produced the Th2 cytokines IL‐4, IL‐5, and IL‐13 (Figure 5). 
Interestingly, mLN cells from mice exposed to peanut and ID also 
produced IFN‐γ, suggesting that ID induced a mixed Th1/Th2 re-
sponse to inhaled peanut (Figure 5). We did not observe consistent 
production of IL‐17A by peanut‐stimulated mLN cells, indicating that 
neither peanut nor ID had significant Th17 adjuvant activity (data 
not shown).
IL‐4 is traditionally considered to be a marker of Th2 differen-
tiation.25 However, Tfh cells are also a major source of IL‐4 in LNs 
and are necessary for IgE responses against inhaled allergens.15,27,28 
Therefore, we investigated whether ID influenced the number of 
Tfh cells in lung‐draining mLNs. Compared to peanut or ID alone, 
coexposure to inhaled peanut and ID for two weeks resulted 
F I G U R E  3   ID induces innate cytokine production in murine 
lungs and human bronchial epithelial cells. A, Quantities of IL‐1α, 
IL‐1β, IL‐33, and TSLP in mouse lung homogenates at 6 h following 
exposure to inhaled PBS, PN, ID, or PN + ID. Bars represent 
mean ± SEM, and individual data points are shown (n = 5‐6 mice per 
group). B, Quantities of IL‐1α and IL‐1β in apical cell washes from 
primary human bronchial epithelial cells at 4 h following treatment 
with PBS, PN, ID, or PN + ID. Bars represent mean ± SEM, and 
individual data points are shown (n = 3 donors). *P < .05, **P < .01, 
***P < .001, one‐way ANOVA. ID, indoor dust; PN, peanut
in a significant increase in the percentage and total number of 
PD1+CXCR5+ Tfh cells in mLNs (Figure 6A,B). The increase in Tfh 
cells was also associated with an increase in the number of CD19+ B 
cells in mLN (Figure 6C). These findings, along with the significantly 
elevated peanut‐specific immunoglobulin levels (Figure 1B) in mice 
exposed to peanut and ID, suggest that ID is a potent adjuvant for 
IgE responses against inhaled antigens.
4  | DISCUSSION
The increasing prevalence of PA cannot be explained by genet-
ics alone, indicating that environmental factors play an important 
role in PA development. Because children spend the vast majority 
of their lives indoors, it is likely that exposures within the home 
environment influence allergic disease development.58 Within 
the home, children are exposed to a variety of immunostimula-
tory molecules, including allergens and microbial products, which 
can act as adjuvants in the respiratory tract and promote allergic 
sensitization to inhaled antigens.36,41,42,45 While indoor environ-
mental exposures are known to contribute to wheezing and asthma 
inception in children,59 there is increasing evidence that the home 
environment may also impact food allergy development.9,60,61 
Although levels of peanut allergen in the home have been posi-
tively associated with peanut sensitization, it is likely that immu-
nogenic agents within the indoor environment also influence PA 
development. Using an animal model that mimics indoor exposure 
to environmental peanut, we found that inhalational coexposure 
to peanut and ID resulted in sensitization and PA development. 
Inhaled ID activated innate immune responses in the lungs and 
induced migration of peanut‐laden cDCs to lung‐draining LNs. In 
addition, inhaled ID promoted the development of peanut‐specific 
Th2 and accumulation of Tfh cells in lung‐draining LNs, which was 
associated with increased numbers of B cells and production of 
peanut‐specific IgE. Taken together, these findings suggest that in 
addition to the levels of peanut allergen in the home, the adjuvant 
activity of indoor dust is also a determinant of peanut sensitization 
and possibly PA development.
F I G U R E  4   Indoor dust enhances 
migration of peanut‐laden cDC1s to 
lung‐draining LNs. A, B, Flow cytometric 
analysis of lung cDC subsets 24 h 
after airway fluorescent PN‐AF647 
antigen alone or combined with ID. A, 
Representative cytograms of PN‐AF647 
uptake by lung cDC1 or cDC2 subsets. 
Mice treated with ID alone were included 
for gating controls. Numbers represent 
the frequency of cells within each gate. 
B, Percentage of PN‐AF647+ cDC1s and 
cDC2s in lungs. C‐F, Flow cytometric 
analysis of migratory and resident cDC 
subsets in lung‐draining mLNs at 24 h 
following airway instillation of PN ± ID. 
C, Total number of migratory and 
resident cDC subsets in LNs. D, Median 
fluorescence intensity (MFI) of CD40 
and CD86 expression by cDC subsets in 
LNs. E, Representative histograms (left) 
of PN‐AF647 uptake by migratory cDC1s 
or cDC2s in LNs (green histograms). 
Mice receiving ID alone were included 
as gating controls (gray histograms). The 
percentage of PN‐AF647+ cDC subsets 
in LNs is displayed in the graph (right). F, 
Total number of PN‐AF647+ migratory 
and resident cDC subsets in LNs. Bars 
represent means ± SEM (n = 4‐5 mice 
per group). Data shown are from a single 
experiment, representative of two 
experiments. *P < .05, **P < .01, Student's t 
test. ID, indoor dust; PN, peanut
The classic paradigm of food allergy pathogenesis is that food 
allergen sensitization initially occurs in the gastrointestinal tract 
after oral exposure.62 However, the vast majority of children with 
PA react upon their first known ingestion of peanut,4 suggesting 
that sensitization may have occurred through a non‐enteral route. 
Furthermore, the landmark Learning Early About Peanut Allergy 
(LEAP) trial demonstrated that oral exposure to peanut during in-
fancy resulted in tolerance instead of allergy.5 To account for these 
observations, the dual‐allergen exposure hypothesis was recently 
proposed as a model for food allergy development during early child-
hood.63 This hypothesis postulates that early oral exposure to food 
allergens induces tolerance, whereas exposure at non‐enteral sites, 
such as the skin or respiratory tract, results in food sensitization and 
allergy development. In support of the dual‐allergen hypothesis, 
animal studies have shown that cutaneous or inhalational exposure 
to food allergens results in sensitization.15‐17,64,65 In humans, appli-
cation of peanut oil to eczematous skin has been associated with 
PA development.10 In addition, high levels of environmental peanut 
exposure (as estimated by household peanut consumption) are as-
sociated with increased risk for PA; however, this risk was mitigated 
by early oral exposure to peanut.7 Moreover, peanut allergen levels 
in household dust directly correlate with rates of peanut sensitiza-
tion and probable allergy in children.8,9 The effect of environmental 
peanut exposure on PA risk is augmented in children with severe 
atopic dermatitis9 or filaggrin loss‐of‐function mutations,8 suggest-
ing that an impaired skin barrier facilitates epicutaneous sensitiza-
tion to peanut in household dust. While most human studies have 
focused on cutaneous exposure to environmental peanut, sensitiza-
tion may also occur through the respiratory tract. Although peanut 
allergen is not thought to be airborne under ambient conditions,11 
disruption of dust during domestic activity could conceivably lead 
to airborne peanut allergens, as has been observed for house dust 
mite allergens.66 Additionally, peanut‐specific CD4+ T cells from PA 
subjects have increased expression of the airway‐homing chemo-
kine receptor CCR4 but not the skin‐homing molecule cutaneous 
lymphocyte‐associated antigen (CLA) or skin‐homing chemokine re-
ceptor CCR10, suggesting that peanut sensitization occurred in the 
lungs.18 Thus, both the skin and respiratory tract are plausible sites 
for sensitization to environmental peanut.
Indoor dust contains an environmentally relevant mixture of im-
munomodulatory agents to which children are exposed.67 Exposure 
to several of these agents, including indoor allergens and endotoxin, 
has been associated with an increased risk of asthma develop-
ment.68,69 However, many observational studies suggest that early‐
life exposure to allergens and microbes confers protection against 
asthma.70‐73 The reason for this apparent discrepancy is unclear, 
but may depend upon the composition of the home microbiota or 
other environmental factors such as tobacco smoke exposure.74 In 
contrast to asthma, relatively little is known regarding how indoor 
environmental factors impact food allergy development. In a cohort 
from the Urban Environment and Childhood Asthma study, neither 
food sensitization nor food allergy were associated with exposure to 
indoor allergens during the first year of life.60 Interestingly, higher 
endotoxin levels were associated with protection against the devel-
opment of overall food allergy, but not peanut allergy.60 The indoor 
dust sample used for our studies had low levels of endotoxin, which 
may facilitate allergic airway sensitization to inhaled antigens.75 It 
will be interesting to determine whether indoor dust from homes 
with higher levels of endotoxin or other microbial‐derived prod-
ucts prevents sensitization to inhaled peanut. It is also possible that 
the presence of certain immunogenic molecules in indoor dust is a 
prerequisite for airway sensitization to inhaled peanut. While the 
identity of these components is unknown, we have found that heat‐
treated ID retains its adjuvant activity (data not shown), suggest-
ing that proteases or other heat‐sensitive proteins are not involved. 
Identifying the key components of indoor dust that promote allergic 
airway sensitization is currently underway.
During allergic sensitization, allergens or environmental adju-
vants trigger airway epithelial cells to release innate cytokines (IL‐1, 
IL‐33, TSLP) that promote the development of Th2 responses.20 We 
observed that acute exposure to inhaled ID triggered the release 
of innate cytokines in murine lungs, which was associated with 
the development of peanut‐specific Th2 cells in lung‐draining LNs. 
Although Th2 cells have historically been considered necessary for 
IgE responses against inhaled allergens, there is growing evidence 
that Tfh cells are also important.15,27 Indeed, a recent report by 
F I G U R E  5   Inhaled ID promotes peanut‐specific Th2 responses 
in lung‐draining LNs. Lung‐draining LN cells were collected from 
mice sensitized to PN, ID or PN + ID twice weekly for 2 wk, and 
then stimulated ex vivo with peanut antigen. Four days later, levels 
of IL‐4, IL‐5, IL‐13, and IFN‐γ in cell culture supernatants were 
measured by ELISA. Bars represent means ± SEM, and individual 
data points are shown (n = 5‐6 mice per group). Data shown are 
from a single experiment, representative of two experiments. 
*P < .05, **P < .01, ***P < .001, one‐way ANOVA. ID, indoor dust; PN,
peanut
Dolence et al found that Tfh cells were essential for IgE responses 
against inhaled peanut.15 In that study, inhaled peanut flour induced 
production of IL‐1α and IL‐1β, which were critical for the develop-
ment of peanut‐specific Tfh cells. We found that peanut extract 
induced only low levels of IL‐1 in the lungs, which is likely due to 
weaker endogenous adjuvant activity of peanut extract compared 
to peanut flour.15 In contrast, we found that inhaled ID triggered ro-
bust production of IL‐1α, IL‐1β, and IL‐33, which was associated with 
increased numbers of Tfh cells in the draining LNs. We also observed 
that ID, but not peanut extract alone, induced IL‐1α and IL‐1β pro-
duction by primary HBECs. While we could not detect production 
of TSLP or IL‐33 by peanut or ID‐treated HBECs, we cannot exclude 
the possibility that these cytokines are induced at later time‐points. 
Indeed, peanut extract has been reported to stimulate IL‐33 mRNA 
expression by human keratinocytes,64 suggesting that peanut aller-
gen can directly stimulate innate responses in epithelial cells. Taken 
together, our findings suggest that environmental adjuvants in in-
door dust can stimulate innate signalling pathways important for Tfh 
development and IgE production against inhaled antigens.
Through their ability to capture antigens and stimulate naïve T 
cells, cDCs play a critical role in initiating adaptive immune responses 
against inhaled allergens.21 While intestinal CD103+ cDC1s have 
been reported to transport ingested peanut antigen to gut‐draining 
LNs,76 the lung DC subset responsible for capturing inhaled peanut 
antigen and shuttling it to LNs is unknown. We found that both lung 
CD103+ cDC1s and CD11b+ cDC2s were able to take up peanut al-
lergen from the airways. Although ID exposure did not affect antigen 
uptake by lung cDCs, it did induce activation and migration of cDCs 
to lung‐draining LN. In contrast to reports showing that cDC1s and 
cDC2s were equivalent in transporting inhaled antigen to mLNs,32 
we found a greater number of peanut‐laden cDC1s compared to 
cDC2s in mLNs. Migration of peanut‐laden cDC1s was associated 
with the differentiation of peanut‐specific Th2 cells and increased 
numbers of Tfh cells in LNs, suggesting that cDC1s may promote IgE 
responses against inhaled peanut. This observation is intriguing, as 
lung cDC2s have been reported to be the primary DC subset that 
induces allergic responses against inhaled allergens.33,35 Moreover, 
cDC2s were recently reported to induce Tfh cell responses against 
inhaled antigens, although this study was performed in the ab-
sence of Th2 adjuvants and therefore IgE responses could not be 
assessed.32 However, we and others have previously found that lung 
cDC1s from ID‐exposed mice are capable of stimulating Th2 cell 
differentiation.34,42 Furthermore, both gut and splenic cDC1s have 
been shown to prime antigen‐specific Tfh cells’ cell responses,76,77 
raising the possibility that lung cDC1s may do the same under certain 
conditions. It is also possible that enhanced degradation of AF647‐
labelled peanut is responsible for the low number of peanut‐laden 
cDC2s present in mediastinal LN. However, AF647+ cDC2s were 
readily detectable in mLN after airway delivery of other AF647‐la-
belled allergens, suggesting that antigen processing is not inherently 
enhanced in this cDC subset.33,34 Identifying the lung cDC subset 
that promotes IgE responses against peanut allergen is under current 
investigation.
In summary, we have found that inhalational exposure to peanut 
and indoor dust results in allergic sensitization and the development 
of PA in a mouse model. These findings suggest that in addition to 
F I G U R E  6   Inhaled ID results in increased T follicular helper cells in lung‐draining LNs. A‐C, Analysis of Tfh cells in lung‐draining 
LNs from mice after two weeks of airway sensitization with either PN, ID, or PN + ID. A, Representative cytograms showing the 
frequency of PD‐1+CXCR5+ Tfh after gating on CD3+CD4+CD44hi cells in mLN. B, Percentage (left) and total number (right) of 
CD3+CD4+CD44hiPD‐1+CXCR5+ Tfh cells in lung‐draining LNs. C, Number of CD19+ B cells in lung‐draining LNs at two weeks following 
airway sensitization with either PN, ID, or PN + ID. Bars represent means ± SEM, and individual data points are shown (n = 6 mice per group). 
Data shown are from a single experiment, representative of two experiments. *P < .05, **P < .01, ***P < .001, one‐way ANOVA. ID, indoor 
dust; PN, peanut
peanut levels within the home, the composition of environmental 
adjuvants in household dust is also an important determinant for PA 
development in children. Identifying the key components of indoor 
dust that either promote or protect against peanut sensitization may 
lead to novel environmental interventions aimed at reducing PA de-
velopment in at‐risk children.
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